Rigel Pharmaceuticals, Inc. (RIGL)
47.15
+0.18
(+0.38%)
USD |
NASDAQ |
Oct 02, 16:00
47.12
-0.03
(-0.06%)
After-Hours: 20:00
Rigel Pharmaceuticals Price : 47.15 for Oct. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 47.66 | 48.00 | 46.45 | 47.15 | 185674.0 |
| Oct 01, 2026 | 48.05 | 48.87 | 46.81 | 46.97 | 234999.0 |
| Sep 30, 2026 | 49.27 | 49.70 | 47.80 | 48.15 | 252210.0 |
| Sep 29, 2026 | 49.38 | 49.70 | 48.61 | 48.89 | 182256.0 |
| Sep 28, 2026 | 48.16 | 49.64 | 47.49 | 49.36 | 180879.0 |
| Sep 25, 2026 | 48.23 | 48.53 | 47.20 | 48.18 | 204930.0 |
| Sep 24, 2026 | 47.87 | 48.14 | 47.00 | 47.89 | 143825.0 |
| Sep 23, 2026 | 48.62 | 48.69 | 46.91 | 48.13 | 151375.0 |
| Sep 22, 2026 | 47.50 | 49.02 | 47.23 | 48.82 | 242877.0 |
| Sep 21, 2026 | 47.13 | 47.50 | 46.49 | 47.09 | 164839.0 |
| Sep 18, 2026 | 45.54 | 46.99 | 45.24 | 46.64 | 939570.0 |
| Sep 17, 2026 | 45.25 | 46.27 | 45.14 | 45.85 | 165748.0 |
| Sep 16, 2026 | 44.14 | 45.37 | 43.78 | 44.48 | 226406.0 |
| Sep 15, 2026 | 45.14 | 46.26 | 44.22 | 44.36 | 269889.0 |
| Sep 14, 2026 | 47.32 | 47.53 | 44.96 | 45.35 | 335807.0 |
| Sep 11, 2026 | 47.84 | 47.86 | 47.00 | 47.24 | 187183.0 |
| Sep 10, 2026 | 46.69 | 47.35 | 46.28 | 47.28 | 131329.0 |
| Sep 09, 2026 | 46.85 | 47.88 | 46.78 | 47.22 | 177149.0 |
| Sep 08, 2026 | 48.09 | 48.11 | 46.61 | 47.37 | 248396.0 |
| Sep 04, 2026 | 48.04 | 48.87 | 47.77 | 48.67 | 104968.0 |
| Sep 03, 2026 | 49.51 | 49.90 | 48.09 | 48.50 | 190390.0 |
| Sep 02, 2026 | 48.00 | 49.70 | 47.73 | 49.42 | 184700.0 |
| Sep 01, 2026 | 46.15 | 47.85 | 46.15 | 47.50 | 205505.0 |
| Aug 31, 2026 | 46.04 | 46.59 | 45.31 | 46.18 | 243090.0 |
| Aug 28, 2026 | 46.46 | 46.79 | 45.68 | 46.48 | 246125.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Cytokinetics, Inc. | 65.60 |
| Ironwood Pharmaceuticals, Inc. | 3.64 |
| Capricor Therapeutics, Inc. | 8.95 |
| ACADIA Pharmaceuticals, Inc. | 19.95 |
| Alnylam Pharmaceuticals, Inc. | 219.72 |
Price Related Metrics
| PE Ratio | 2.889 |
| PS Ratio | 3.331 |
| PEG Ratio | 0.0143 |
| Price to Book Value | 2.067 |
| Price to Free Cash Flow | 101.95 |
| Earnings Yield | 34.62% |
| Market Cap | 879.53M |
| PEGY Ratio | 0.0143 |
| Operating PE Ratio | 10.59 |
| Normalized PE Ratio | 2.887 |